Literature DB >> 9019170

Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism.

J R Gasdaska1, M Berggren, G Powis.   

Abstract

Thioredoxins are a class of low molecular weight redox proteins that undergo reversible reduction-oxidation of two active-site cysteine residues with reduction catalyzed by the NADPH-dependent flavoenzyme thioredoxin reductase. Human thioredoxin has been shown to be identical to a previously reported leukemic cell growth factor. We now report that recombinant human thioredoxin added to minimal culture medium in the absence of serum stimulates the proliferation of a number of human solid tumor cell lines measured over several days. The concentration of thioredoxin producing half-maximal stimulation of MCF-7 breast cancer cell proliferation was 350 nM, and the maximum stimulation occurred at 5 microM. The maximum increase in cell proliferation caused by thioredoxin was up to 90% of that seen with 10% bovine serum in the medium. There was a positive correlation between the ability of cell lines to proliferate in minimal medium, presumably, due to the autocrine production of growth factors by the cells, and the stimulation of proliferation by thioredoxin. Neither a redox inactive, mutant human thioredoxin, C32S/C35S, nor reduced Escherichia coli thioredoxin were able to stimulate MCF-7 cell proliferation. MCF-7 cell proliferation caused by human thioredoxin was completely abolished if the culture medium was changed each day. Antibody to thioredoxin blocked the cell proliferation caused by thioredoxin. Studies with 125I-labeled thioredoxin showed time-dependent binding to the surface of MCF-7 cells, but the binding was not saturable, indicating the absence of specific binding of thioredoxin to a cell surface receptor. Most of the thioredoxin associated with the cell could be released by trypsinization, and relatively little intact thioredoxin was taken up by the cell. The results of the study suggest that thioredoxin acts by a novel helper, redox mechanism to increase the cell proliferation response to growth factor(s) produced by the cell itself.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9019170

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  25 in total

Review 1.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

2.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator.

Authors:  S Hayashi; K Hajiro-Nakanishi; Y Makino; H Eguchi; J Yodoi; H Tanaka
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  Dissection of complex protein dynamics in human thioredoxin.

Authors:  Weihong Qiu; Lijuan Wang; Wenyun Lu; Amanda Boechler; David A R Sanders; Dongping Zhong
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

4.  Positional cloning of the combined hyperlipidemia gene Hyplip1.

Authors:  Jackie S Bodnar; Aurobindo Chatterjee; Lawrence W Castellani; David A Ross; Jeffrey Ohmen; James Cavalcoli; Chenyan Wu; Katherine M Dains; Joe Catanese; Michael Chu; Sonal S Sheth; Kanti Charugundla; Peter Demant; David B West; Pieter de Jong; Aldons J Lusis
Journal:  Nat Genet       Date:  2001-12-20       Impact factor: 38.330

5.  Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases.

Authors:  I Kerblat; C Drouet; S Chesne; P N Marche
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

6.  Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy.

Authors:  S Pontikakis; C Papadaki; M Tzardi; M Trypaki; M Sfakianaki; F Koinis; E Lagoudaki; L Giannikaki; A Kalykaki; E Kontopodis; Z Saridaki; N Malamos; V Georgoulias; J Souglakos
Journal:  Pharmacogenomics J       Date:  2016-10-25       Impact factor: 3.550

7.  Growth promoting effect of thioredoxin on intestinal epithelial cells.

Authors:  Shigeo Takaishi; Mitsutaka Sawada; Hiroshi Seno; Takahisa Kayahara; Yukari Morita-Fujisawa; Hiroaki Fukuzawa; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

Review 8.  Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology.

Authors:  Melissa Kemp; Young-Mi Go; Dean P Jones
Journal:  Free Radic Biol Med       Date:  2007-11-28       Impact factor: 7.376

9.  Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.

Authors:  Motoaki Nagano; Kinta Hatakeyama; Masahiro Kai; Hajime Nakamura; Junji Yodoi; Yujiro Asada; Kazuo Chijiiwa
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

10.  Thioredoxin-1 redox signaling regulates cell survival in response to hyperoxia.

Authors:  Miranda J Floen; Benjamin J Forred; Elliot J Bloom; Peter F Vitiello
Journal:  Free Radic Biol Med       Date:  2014-08-06       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.